SCHEMBL94368

SCHEMBL94368

[CH2]c1ccc(C(=O)NCc2ccccc2OC)cc1

nearest known ligand 0.77

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.77
HTT P42858 1/20 0.75
HPGD P15428 5/20 0.70
ALDH1A1 P00352 4/20 0.65
GAA P10253 1/20 0.64
MAPT P10636 2/20 0.62
LMNA P02545 1/20 0.60
POLB P06746 2/20 0.60
KDM4E B2RXH2 1/20 0.59
RCE1 Q9Y256 1/20 0.59
NAMPT P43490 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6848785 0.88 HTT (0.83) HDAC1HTTHPGDALDH1A1GAA
SCHEMBL27610689 0.87 HDAC1 (0.79) HDAC1HTTHPGDALDH1A1GAA
SCHEMBL6570631 0.87 HDAC1 (1.00) HDAC1HTTHPGDALDH1A1GAA
SCHEMBL13947285 0.87 HDAC1 (0.79) HDAC1HTTHPGDALDH1A1GAA
SCHEMBL12218248 0.86 HDAC1 (0.77) HDAC1HTTHPGDALDH1A1GAA
SCHEMBL12218093 0.86 HDAC1 (0.82) HDAC1HTTHPGDALDH1A1GAA
SCHEMBL3306757 0.83 HTT (0.76) HDAC1HTTHPGDALDH1A1GAA
SCHEMBL6506444 0.83 HDAC1 (0.73) HDAC1HTTHPGDALDH1A1GAA
SCHEMBL1568381 0.83 HDAC1 (0.72) HDAC1HTTHPGDALDH1A1GAA
SCHEMBL11901119 0.82 HPGD (0.84) HDAC1HTTHPGDALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB HDAC1 476/4885HTT 4495/4885HPGD 2146/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 HDAC1 1814/4885HTT 4175/4885HPGD 2322/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 HDAC1 1814/4885HTT 4175/4885HPGD 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.